Versant Capital Management, Inc Regenxbio Inc. Transaction History
Versant Capital Management, Inc
- $454 Million
- Q4 2024
A detailed history of Versant Capital Management, Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,401 shares of RGNX stock, worth $11,306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,401
Previous 1,110
26.22%
Holding current value
$11,306
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RGNX
# of Institutions
186Shares Held
43.1MCall Options Held
104KPut Options Held
478K-
Black Rock Inc. New York, NY8.61MShares$69.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.89MShares$39.5 Million3.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.37MShares$35.3 Million0.0% of portfolio
-
State Street Corp Boston, MA2.78MShares$22.5 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.48MShares$20 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $349M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...